Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway.
Membrane formation and the initiation of myelin gene expression are hallmarks of the differentiation of oligodendrocytes from their precursors. Here, we compared the roles of the two related extracellular matrix (ECM) glycoproteins Tenascin C (Tnc) and Tenascin R (Tnr) in oligodendrocyte differentiation. Oligodendrocyte precursors from Tnr-deficient mice exhibited reduced differentiation, as revealed by retarded expression of myelin basic protein (MBP) in culture. This could be rescued with purified Tnr. In contrast, when we cultured oligodendrocytes on a Tnc-containing, astrocyte-derived ECM, they barely expressed MBP. This inhibition could be overcome when we used ECM from astrocytes deficient for Tnc, suggesting that Tnc inhibits differentiation. In contrast to their antagonistic effect on differentiation, both Tnc and Tnr similarly inhibited morphologic maturation. When oligodendrocytes were cultured on the purified glycoproteins, process elaboration and membrane expansion were reduced. Both Tnc and Tnr interfered with the activation of the small GTPase RhoA. Conversely, RhoA and Rac1 activation induced by cytotoxic necrotizing factor 1 (CNF1) increased the formation of myelin membranes, whereas Y27632-mediated inhibition of the Rho-cascade prevented it without, however, affecting the fraction of MBP-expressing cells. Because Tnc and Tnr play antagonistic roles for differentiation and comparably inhibit morphologic maturation, we conclude that independent molecular pathways regulate these processes.
Czopka
Tim
T
Department of Cell Morphology and Molecular Neurobiology, Ruhr-University, Bochum, Germany.
Von Holst
Alexander
A
Schmidt
Gudula
G
Ffrench-Constant
Charles
C
Faissner
Andreas
A
D000577:Amides / Q000494:pharmacology; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D015153:Blotting, Western; D001921:Brain / Q000166:cytology / Q000378:metabolism; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology; D048430:Cell Shape / Q000502:physiology; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018507:Gene Expression Regulation, Developmental; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D051379:Mice; D018345:Mice, Knockout; D004676:Myelin Basic Protein / Q000235:genetics / Q000378:metabolism*; D009186:Myelin Sheath / Q000187:drug effects / Q000378:metabolism*; D009413:Nerve Fibers, Myelinated / Q000378:metabolism; D009836:Oligodendroglia / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D019063:Tenascin / Q000235:genetics / Q000378:metabolism*; D020741:rho GTP-Binding Proteins / Q000378:metabolism*
D000577:Amides; D004791:Enzyme Inhibitors; D004676:Myelin Basic Protein; D011725:Pyridines; D019063:Tenascin; C108830:Y 27632; D020741:rho GTP-Binding Proteins